Tempest Therapeutics, Inc. Deferred Tax Assets, Tax Credit Carryforwards
Tempest Therapeutics, Inc. (TPST) had Deferred Tax Assets, Tax Credit Carryforwards of $3.94 million as of 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxCreditCarryforwards · last filed 2018-03-15
- 2017-12-31: Deferred Tax Assets, Tax Credit Carryforwards $3.94M.
- 2016-12-31: Deferred Tax Assets, Tax Credit Carryforwards $3.03M.
- 2015-12-31: Deferred Tax Assets, Tax Credit Carryforwards $2.30M.
- 2014-12-31: Deferred Tax Assets, Tax Credit Carryforwards $1.69M.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards |
|---|---|
| 2017-12-31 | $3.94M 10-K · filed 2018-03-15 |
| 2016-12-31 | $3.03M 10-K · filed 2018-03-15 |
| 2015-12-31 | $2.30M 10-K · filed 2017-03-02 |
| 2014-12-31 | $1.69M 10-K · filed 2016-02-26 |
| 2013-12-31 | $823.00K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |